AbbVie and Xilio Therapeutics, Inc., a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced a collaboration...
Bugworks Research Inc., a clinical stage biopharmaceutical company, and Cytecare Cancer Hospitals announced the launch of a first-of-its-kind collaboration. Bugworks develops best-in-class, novel therapies...
